Your browser doesn't support javascript.
loading
Chondrotoxicity of Intra-Articular Injection Treatment: A Scoping Review.
Pirri, Carmelo; Sorbino, Andrea; Manocchio, Nicola; Pirri, Nina; Devito, Antonio; Foti, Calogero; Migliore, Alberto.
Affiliation
  • Pirri C; Department of Neurosciences, Institute of Human Anatomy, University of Padova, 35121 Padova, Italy.
  • Sorbino A; Physical and Rehabilitation Medicine, Department of Clinical Sciences and Translational Medicine, Tor Vergata University, 00133 Rome, Italy.
  • Manocchio N; Physical and Rehabilitation Medicine, Department of Clinical Sciences and Translational Medicine, Tor Vergata University, 00133 Rome, Italy.
  • Pirri N; Department of Medicine-DIMED, School of Radiology, Radiology Institute, University of Padova, 35121 Padova, Italy.
  • Devito A; Internal Medicine, S. Pietro Fatebenefratelli Hospital, 00189 Rome, Italy.
  • Foti C; Physical and Rehabilitation Medicine, Department of Clinical Sciences and Translational Medicine, Tor Vergata University, 00133 Rome, Italy.
  • Migliore A; Rheumatology, S. Pietro Fatebenefratelli Hospital, 00189 Rome, Italy.
Int J Mol Sci ; 25(13)2024 Jun 26.
Article in En | MEDLINE | ID: mdl-39000119
ABSTRACT
The purpose of this scoping review was to identify possible chondrotoxic effects caused by drugs usually used for intra-articular injections. PubMed, Scopus, Web of Science and Cochrane were searched. Inclusion criteria required randomized controlled trials written in English that evaluate the toxic effect that damages the cartilage. The literature search resulted in 185 unique articles. 133 full-text articles were screened for inclusion, of which 65 were included. Corticosteroids, with the exception of triamcinolone, along with local anaesthetics, potentially excluding ropivacaine and liposomal bupivacaine, and nonsteroidal anti-inflammatory drugs, exhibited insufficient safety profiles to warrant casual use in clinical settings. Hyaluronic acid, on the other hand, appears to demonstrate safety while also mitigating risks associated with concurrent compounds, thereby facilitating therapeutic combinations. Additionally, there remains a paucity of data regarding platelet-rich plasma, necessitating further evaluation of its potential efficacy and safety. Overall, it seems that results are significantly influenced by the dosage and frequency of injections administered, observed in both human and animal studies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hyaluronic Acid Limits: Animals / Humans Language: En Journal: Int J Mol Sci Year: 2024 Document type: Article Affiliation country: Italia Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hyaluronic Acid Limits: Animals / Humans Language: En Journal: Int J Mol Sci Year: 2024 Document type: Article Affiliation country: Italia Country of publication: Suiza